Hamilelikte 3-benzylidene camphor kullanmaktan kaçınmalı mıyım? | VeriMom
Authoritative safety review (SCCS, 2013) found multiple in vitro hormonal activities (estrogenic, anti‑estrogenic and anti‑androgenic) and in vivo changes in hormone‑responsive gene expression; SCCS concluded use as a UV filter up to 2% was not safe. ECHA has listed 3‑benzylidene camphor on the REACH Candidate List as an SVHC for endocrine‑disrupting properties and the ingredient is subject to cosmetic prohibitions in EU Annex II. Taken together this supports 'suspected' reproductive/fetal hazard (H=2), demonstrated hormonal mechanisms (M=2) and measurable systemic exposure from topical use (E=2).
ECHA regulatory hazard statements
- •H361
What to use instead
Pregnancy-safe ingredients that serve a similar function:
FAQ
- 3-benzylidene camphor hamilelikte güvenli mi?
- Authoritative safety review (SCCS, 2013) found multiple in vitro hormonal activities (estrogenic, anti‑estrogenic and anti‑androgenic) and in vivo changes in hormone‑responsive gene expression; SCCS concluded use as a UV filter up to 2% was not safe. ECHA has listed 3‑benzylidene camphor on the REACH Candidate List as an SVHC for endocrine‑disrupting properties and the ingredient is subject to cosmetic prohibitions in EU Annex II. Taken together this supports 'suspected' reproductive/fetal hazard (H=2), demonstrated hormonal mechanisms (M=2) and measurable systemic exposure from topical use (E=2).
- 3-benzylidene camphor emzirirken güvenli mi?
- Same hazard/mechanistic evidence applies (endocrine activity, SCCS concerns; ECHA SVHC listing). Topical cosmetic application can produce measurable systemic levels for lipophilic UV‑filter type compounds, so moderate exposure to the nursing parent (and potential low‑to‑moderate transfer to milk) is plausible though direct milk‑transfer data are lacking; therefore exposure scored as moderate (E=2).
- 3-benzylidene camphor bebek cildi için güvenli mi?
- Hazard and mechanism as above (SCCS: endocrine activity; ECHA: SVHC for endocrine disruption). Because infants 0–3 years have an immature skin barrier and higher surface‑area‑to‑body‑weight, exposure score is increased by +1 relative to adult topical exposure (adult E=2 → infant E=3). Infants may therefore be at higher internal exposure and greater sensitivity to hormonal perturbation.
- VeriMom 3-benzylidene camphor nasıl puanlıyor?
- VeriMom 3-benzylidene camphor'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 13/100 (yüksek risk) olarak puanlar.
- Hamilelikte 3-benzylidene camphor yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.